Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 148

1.
2.

Lipid nanocarriers: influence of lipids on product development and pharmacokinetics.

Pathak K, Keshri L, Shah M.

Crit Rev Ther Drug Carrier Syst. 2011;28(4):357-93. Review.

PMID:
21967401
3.

Gelatin-based nanoparticles as drug and gene delivery systems: reviewing three decades of research.

Elzoghby AO.

J Control Release. 2013 Dec 28;172(3):1075-91. doi: 10.1016/j.jconrel.2013.09.019. Epub 2013 Oct 2. Review.

PMID:
24096021
4.

Virus-based nanocarriers for drug delivery.

Ma Y, Nolte RJ, Cornelissen JJ.

Adv Drug Deliv Rev. 2012 Jun 15;64(9):811-25. doi: 10.1016/j.addr.2012.01.005. Epub 2012 Jan 20. Review.

PMID:
22285585
5.

Lipid-based nanocarriers as an alternative for oral delivery of poorly water- soluble drugs: peroral and mucosal routes.

Silva AC, Santos D, Ferreira D, Lopes CM.

Curr Med Chem. 2012;19(26):4495-510. Review.

PMID:
22834821
6.

SLN, NLC, LDC: state of the art in drug and active delivery.

Attama AA.

Recent Pat Drug Deliv Formul. 2011 Sep;5(3):178-87. Review.

PMID:
21834777
7.

Interaction of nanoparticles and cell-penetrating peptides with skin for transdermal drug delivery.

Desai P, Patlolla RR, Singh M.

Mol Membr Biol. 2010 Oct;27(7):247-59. doi: 10.3109/09687688.2010.522203. Review.

8.

Lipid nanoparticles: state of the art, new preparation methods and challenges in drug delivery.

Battaglia L, Gallarate M.

Expert Opin Drug Deliv. 2012 May;9(5):497-508. doi: 10.1517/17425247.2012.673278. Epub 2012 Mar 22. Review.

9.

Lipid-based nanocarriers for drug delivery and targeting: a patent survey of methods of production and characterization.

Carbone C, Cupri S, Leonardi A, Puglisi G, Pignatello R.

Pharm Pat Anal. 2013 Sep;2(5):665-77. doi: 10.4155/ppa.13.43. Review.

PMID:
24237173
10.

Modification Strategies of Lipid-Based Nanocarriers for Mucosal Drug Delivery.

Wu L, Liu M, Zhu X, Shan W, Huang Y.

Curr Pharm Des. 2015;21(36):5198-211. Review.

PMID:
26412355
11.

Solid lipid nanoparticles: promising therapeutic nanocarriers for drug delivery.

Thukral DK, Dumoga S, Mishra AK.

Curr Drug Deliv. 2014;11(6):771-91. Review.

PMID:
25469779
12.

Nanocarriers for oral drug delivery.

Zhang L, Wang S, Zhang M, Sun J.

J Drug Target. 2013 Jul;21(6):515-27. doi: 10.3109/1061186X.2013.789033. Epub 2013 Apr 26. Review.

PMID:
23621127
13.

Lipid nanoparticles for parenteral delivery of actives.

Joshi MD, Müller RH.

Eur J Pharm Biopharm. 2009 Feb;71(2):161-72. doi: 10.1016/j.ejpb.2008.09.003. Epub 2008 Sep 13. Review.

PMID:
18824097
14.

Solid lipid nanoparticles for ocular drug delivery.

Seyfoddin A, Shaw J, Al-Kassas R.

Drug Deliv. 2010 Sep-Oct;17(7):467-89. doi: 10.3109/10717544.2010.483257. Review.

PMID:
20491540
15.

Preparation and characterization of solid lipid nanoparticles-a review.

Parhi R, Suresh P.

Curr Drug Discov Technol. 2012 Mar;9(1):2-16. Review.

PMID:
22235925
16.

Lipid-based nanoparticles as pharmaceutical drug carriers: from concepts to clinic.

Puri A, Loomis K, Smith B, Lee JH, Yavlovich A, Heldman E, Blumenthal R.

Crit Rev Ther Drug Carrier Syst. 2009;26(6):523-80. Review.

17.

Rationalizing the selection of oral lipid based drug delivery systems by an in vitro dynamic lipolysis model for improved oral bioavailability of poorly water soluble drugs.

Dahan A, Hoffman A.

J Control Release. 2008 Jul 2;129(1):1-10. doi: 10.1016/j.jconrel.2008.03.021. Epub 2008 Apr 1. Review.

PMID:
18499294
18.

Cyclodextrin inclusion complexes loaded in particles as drug carrier systems.

Fraceto LF, Grillo R, Sobarzo-Sánchez E.

Curr Top Med Chem. 2014;14(4):518-25. Review.

PMID:
24354668
19.

Lipid nanoparticles for dermal drug delivery.

Kakadia PG, Conway BR.

Curr Pharm Des. 2015;21(20):2823-9. Review.

PMID:
25925115
20.

Lipid-based drug delivery systems for cancer treatment.

Arias JL, Clares B, Morales ME, Gallardo V, Ruiz MA.

Curr Drug Targets. 2011 Jul 1;12(8):1151-65. Review.

PMID:
21443475

Supplemental Content

Support Center